Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

NCT06956716 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Intrahepatic Cholangiocarcinoma

Interventions

BIOLOGICAL: individualized anti-tumor new antigen iNeo-Vac-R01 injection
DRUG: Gemcitabine + cisplatin (GP)
DRUG: Sintilimab injection

Sponsor

Zhejiang University

Collaborators

[object Object]